LISATA THERAPEUTICS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Lisata Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Lisata Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$4.93M, a 6.29% increase year-over-year.
  • Lisata Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$20.7M, a 3.38% increase year-over-year.
  • Lisata Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$20.8M, a 61.6% increase from 2022.
  • Lisata Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$54.2M, a 97.4% decline from 2021.
  • Lisata Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$27.5M, a 237% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$20.7M -$4.93M +$331K +6.29% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$21.1M -$5.04M -$1.02M -25.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$20.1M -$5.4M +$786K +12.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$20.8M -$5.37M +$625K +10.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$21.5M -$5.26M +$32.1M +85.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$53.6M -$4.03M +$2.6M +39.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$56.2M -$6.19M -$1.96M -46.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$54.2M -$5.99M +$804K +11.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$55M -$37.4M -$30.5M -440% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$24.6M -$6.63M -$944K -16.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$23.6M -$4.23M +$3.84M +47.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$27.5M -$6.79M -$1.36M -25.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$26.1M -$6.93M -$1.6M -30% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$24.5M -$5.68M -$12.3M -186% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$12.2M -$8.06M -$4.07M -102% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$8.15M -$5.43M -$475K -9.58% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-22
Q3 2020 -$7.68M -$5.33M -$429K -8.76% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$7.25M $6.6M +$11.7M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$19M -$3.99M +$377K +8.63% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$19.4M -$4.96M Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$4.9M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$5.14M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$4.37M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2015 -$80.9K -$33.2K -$21.6K Oct 1, 2015 Dec 31, 2015 10-K 2016-03-15
Q3 2015 -$59.3K -$11.4K* +$5.6K Jul 1, 2015 Sep 30, 2015 10-K 2016-03-15
Q2 2015 -$64.9K -$17.1K -$4.52K -35.9% Apr 1, 2015 Jun 30, 2015 10-K 2016-03-15
Q1 2015 -$60.4K -$19.2K -$5.51K -40.2% Jan 1, 2015 Mar 31, 2015 10-K 2016-03-15
Q4 2014 -$54.9K -$11.6K* +$923 Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$55.8K -$17K -$7.9K Jul 1, 2014 Sep 30, 2014 10-K 2016-03-15
Q2 2014 -$47.9K -$12.6K -$4.03K Apr 1, 2014 Jun 30, 2014 10-K 2016-03-15
Q1 2014 -$43.9K -$13.7K -$4.88K Jan 1, 2014 Mar 31, 2014 10-K 2016-03-15
Q4 2013 -$39K -$12.5K +$15.5M +99.9% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-02
Q3 2013 -$15.5M -$9.07K* +$8.4M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-02
Q2 2013 -$23.9M -$8.58K* +$20.5M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-02
Q1 2013 -$44.4M -$8.8K* +$9.34M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-02
Q4 2012 -$53.8M -$15.5M +$3.5M +18.4% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 -$57.3M -$8.41M -$1.06M -14.5% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 -$56.2M -$20.5M -$9.9M -93.3% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 -$46.3M -$9.35M +$825K +8.11% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$47.1M -$19M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-11
Q3 2011 -$7.35M -$206K -2.89% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$10.6M -$5.23M -97.4% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$10.2M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q3 2010 -$7.14M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 -$5.37M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.